XML 79 R58.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Awards Plan (Tables)
12 Months Ended
Dec. 31, 2024
Baidu  
Total Share-Based Compensation Cost Recognized
The following table summarizes the share-based compensation cost recognized by iQIYI:
 
    
For the years ended December 31,
 
    
2022
    
2023
    
2024
    
2024
 
    
RMB
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Cost of revenues
     148        133        121        17  
Selling, general and administrative
     424        315        274        37  
Research and development
     239        189        150        21  
  
 
 
    
 
 
    
 
 
    
 
 
 
     811        637        545        75  
  
 
 
    
 
 
    
 
 
    
 
 
 
Option Activity
The following table summarizes the option activity for the year ended December 31, 2024:
 
    
Number of share
options
   
Weighted average

exercise price
(US$)
    
Weighted
average
remaining
contractual life

(Years)
    
Aggregate
intrinsic
value (US$ in
millions)
 
Incentive share options
          
Outstanding, December 31, 2023
     17,783,120               19                4.4                17  
  
 
 
   
 
 
    
 
 
    
 
 
 
Granted
     —        —         
Exercised
     (473,608     12        
Forfeited/Cancelled
     (945,728     21        
  
 
 
   
 
 
    
 
 
    
 
 
 
Outstanding, December 31, 2024
     16,363,784       19        3.4        —   
  
 
 
   
 
 
    
 
 
    
 
 
 
Vested and expected to vest at December 31, 2024
     16,242,440       19        3.3        —   
  
 
 
   
 
 
    
 
 
    
 
 
 
Exercisable at December 31, 2024
     15,650,408       19        3.2        —   
  
 
 
   
 
 
    
 
 
    
 
 
 
Assumptions Used to Estimate Fair Values of Share Options Granted
The following table presents the assumptions used to estimate the fair values of the share options granted in the years presented:
 
    
For the years ended
December 31,
 
    
2022
 
Risk-free interest rate
     1.92~2.96%  
Dividend yield
     —   
Expected volatility range
     40.66%~47.03%  
Expected life (in years)
     5.26~5.49  
Restricted Shares Activity
Restricted Shares activity for the year ended December 31, 2024 was as follow:
 
    
Number of shares
    
Weighted average grant date
fair value (US$)
 
Restricted Shares
     
Unvested, December 31, 2023
     96,162,088                17  
  
 
 
    
 
 
 
Granted
     38,388,408        11  
Vested
     (34,843,528      17  
Forfeited/Cancelled
     (17,385,064      16  
  
 
 
    
 
 
 
Unvested, December 31, 2024
     82,321,904        15  
  
 
 
    
 
 
 
iQIYI  
Total Share-Based Compensation Cost Recognized
The following table summarizes the total share-based compensation cost recognized by the Group:
 
    
For the years ended December 31,
 
    
2022
    
2023
    
2024
    
202
 
    
RMB
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Cost of revenues
     409        590        461        63  
Selling, general and administrative
     1,750        1,678        1,427        195  
Research and development
     4,629        4,077        2,896        397  
  
 
 
    
 
 
    
 
 
    
 
 
 
     6,788        6,345        4,784        655  
  
 
 
    
 
 
    
 
 
    
 
 
 
Option Activity
The following table sets forth the summary of employee option activity for the year ended December 31, 2024:
 
    
Number of
share options
    
Weighted
average
exercise price

(US$)
    
Weighted
average
remaining
contractual life

(Years)
    
Aggregate
Intrinsic
value (US$ in
millions)
 
Outstanding, December 31, 2023
     532,286,814            0.31            6.3            205  
  
 
 
    
 
 
    
 
 
    
 
 
 
Granted
     80,139,500        0.01        
Forfeited/Expired
     (10,216,305      0.12        
Exercised
     (23,754,087      0.23        
  
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding, December 31, 2024
     578,455,922        0.28        6.5        73  
  
 
 
    
 
 
    
 
 
    
 
 
 
Vested and expected to vest at December 31, 2024
     563,629,595        0.28        6.4        69  
  
 
 
    
 
 
    
 
 
    
 
 
 
Exercisable at December 31, 2024
     368,205,208        0.40        5.4        19